Catalyst Wire Dossier Catalyst Wire Dossier

hMG-HP (Meriofert)

human menopausal gonadotropin -HP
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hMG-HP (Meriofert), covering 2019-02-25 to 2019-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle. [Phase 4]

See pricing